Sign in

CIK 0001005286 · Accelerated filer<br>Smaller reporting company

LIFECORE BIOMEDICAL, INC. \DE\

Sign in to watch
Ticker
LFCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
May 25
Incorporated
DE
Entity type
operating
EIN
943025618
Phone
9523684300
Business address
3515 LYMAN BOULEVARD, CHASKA, MN, 55318
Former names
LANDEC CORP \CA\
  1. 4 Shares withheld for taxes Chief Legal & Administration gave up 11,022 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Financial Officer gave up 32,806 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Executive Officer gave up 54,857 shares (to pay taxes)
  4. 4 Open-market sale 10% owner sold 1,386,060 shares at an average $6.59 ($9,132,503)
  5. 4 Shares withheld for taxes Chief Executive Officer gave up 21,532 shares (to pay taxes)
  6. 4 Open-market sale 10% owner sold 12,334 shares at $7.00 ($86,353)
  7. 4 Open-market sale 10% owner sold 51,496 shares at an average $7.03 ($362,019)
  8. 4 Open-market sale 10% owner sold 41,091 shares at an average $7.05 ($289,869)
  9. 4 Grant or award Chief Legal & Administration acquired 215,000 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market buy Chief Executive Officer bought 17,000 shares at $5.74 ($97,580)
  12. 4 Shares withheld for taxes Chief Executive Officer gave up 11,769 shares (to pay taxes)
  13. 4 Shares withheld for taxes Chief Financial Officer gave up 5,653 shares (to pay taxes)
  14. 4 Shares withheld for taxes Chief Financial Officer gave up 34,138 shares (to pay taxes)
  15. 4 Open-market buy 10% owner bought 292,683 shares at $4.10 ($1,200,000)
  16. 4 Open-market buy Director bought 1,463,414 shares at $4.10 ($5,999,997)
  17. 4/A Grant or award Director acquired 24,554 shares (grant or award)
  18. 4 Grant or award Chief Financial Officer acquired 262,500 shares (grant or award)
  19. 3 Insider Initial Statement of Ownership
  20. 4 Grant or award Director acquired 24,554 shares (grant or award)

Page 2 of 47 · 936 filings